Impact Factor
3.00
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.26
241 total citations
h5-index
21
h5 depth signal
Cited share
60.5%
72 of 119
Total citations
241
Citation footprint
Metric signal
2.00
External metric anchor
Self-citation
0.0%
0 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
China
247
Japan
70
United States
39
Germany
31
South Korea
25
Citing Fields of Research
Cardiology
80
Physiology
65
Phytochemicals
62
Pharmacology & Toxicology
59
Diabetes
54
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
6,670
Articles tracked across the journal lifetime
Indexed publication set
119
72 cited publications
Last 12 months
31
2.8 publications/month
Open access share
29.0%
9 OA publications in the last year
Leading citing country
China
247 citing publications
Leading citing field
Cardiology
80 citing publications
Latest tracked publication
15 October 2026
10 recent records available
Coverage & Indexing History
v1n1, 1968-
v1n1, 1968-
Active Coverage
Research Focus & Classification
Indexed Subjects
Musculoskeletal Disorders
Cancer, Autophagy & Apoptosis
Immunology
Physiology
Phytochemicals
Cardiology
Lung Cancer
Broad Categories
Pharmacology
Cancer, Autophagy & Apoptosis
Cardiology
Urology
Allergies
Musculoskeletal Disorders
Noncoding RNA
Diabetes
MeSH Descriptors
Pharmacology
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1159/pha/aejag007
Open DOI
Regulation of 5-hydroxytryptamine secretion mediated by quercetin-modulated TRPA1 activity in RIN-14B cells
Quercetin, a dietary flavonoid, contributes to bowel regulation and anti-inflammatory effects. Enterochromaffin (EC) cells express transient receptor potential ankyrin1 (TRPA1) and significantly contribute to gastrointestinal motility an...
02
DOI 10.1159/pha/aejag008
Open DOI
Pharmacological and Therapeutic Insights into Gepotidacin: A First-in-Class Triazaacenaphthylene Antibiotic
The growing challenge of antimicrobial resistance has necessitated the development of new antibiotics with novel mechanisms of action. Gepotidacin is a first-in-class triazaacenaphthylene antibiotic developed for the treatment of uncompl...
03
DOI 10.1159/pha/aejag006
Open DOI
Optimizing Perfusates for Ex Vivo Lung Perfusion: A Pharmaceutic Perspective on Formulations, Functions, and Future Innovations
Ex vivo lung perfusion (EVLP) is now an established normothermic machine-perfusion strategy in lung transplantation, primarily enabling structured donor lung assessment, short-term preservation, and selective rehabilitation outside the r...
04
DOI 10.1159/pha/aejag005
Open DOI
Apigenin and Hypertension: A Review of Natural Sources, Pharmacodynamic and Pharmacokinetic Evidence
Purpose: This review aimed to synthesize recent evidence on the pharmacological effects of APG in the management of hypertension. Methods: A comprehensive literature search was conducted using PubMed, Scopus, Web of Science, and Google S...
05
DOI 10.1159/pha/aejag004
Open DOI
Comparative analysis of infarct-reducing properties of ß1 -, ß2 -, and ß3 -adrenergicreceptor ligands in ischemia and reperfusion of the heart
Introduction: In-hospital mortality in patients with acute myocardial infarction and cardiogenic shock can reach 50%. This is because there are currently no drugs approved for clinical use that can radically reduce infarction size and pr...
06
DOI 10.1159/pha/aejag003
Open DOI
Clinical Evidence in Respiratory and Urinary Tract Infections: Focus on Ceftibuten
Background: Antimicrobial resistance (AMR) is one of the most pressing global health problems, resulting from the misuse and overuse of antibiotics across various sectors, which has led to the emergence and spread of resistant microorgan...
07
DOI 10.1159/000552120
Open DOI
Clinical Characteristics, Treatment, and Outcomes of Vancomycin-Induced Linear IgA Bullous Dermatosis
Introduction: This study aimed to elucidate the clinical attributes of vancomycin-induced linear IgA bullous dermatosis (LABD) to enhance diagnostic, therapeutic, and preventive approaches. Methods: We conducted a retrospective analysis ...
08
DOI 10.1159/pha/aejag002
Open DOI
An Open-Label Trial Protocol to Test Menstrual Cycle Effects and Tolerance to Low-Dose Psilocybin in Healthy Menstruating Persons.
Background: Research on the therapeutic benefits of psychedelics, particularly psilocybin, is becoming increasingly popular. Unfortunately, most psychedelic research overlooks the menstrual cycle as a biological variable, raising concern...
09
DOI 10.1159/pha/aejag001
Open DOI
Dexmedetomidine Alleviates Cardiomyocyte Senescence Induced by Ischemia-Reperfusion Injury via Inhibiting the MDH2/NF-κB Pathway
Introduction: Myocardial ischemia-reperfusion (I/R) injury represents a key contributor to cardiac dysfunction and is associated with cardiomyocyte senescence. Dexmedetomidine (Dex) exhibits significant myocardial protective effects, but...
10
DOI 10.1159/000549572
Open DOI
The Co-Regulation of NLRP3 Inflammasome and Autophagy for Cardiovascular Diseases
Background: Cardiovascular diseases (CVDs) represent a significant global public health challenge. Activation of the NLRP3 inflammasome contributes to CVD pathogenesis, while autophagy mitigates the condition by eliminating harmful metab...
Bibliographical & Catalog Notes
No. of issues per vol and the no. of vols. varies, 2002-
Supplements accompany some numbers.
Also issued online.
Vol. 20, no. 1 (1980)19920831 Notice published Printed on acid-free paper